1. Introduction

Cybersecurity certification schemes for medical devices are structured systems through which connected medical devices, their software, and related digital components are independently evaluated against defined cybersecurity standards. Recognition of these schemes determines whether regulators, healthcare institutions, procurement authorities, and other jurisdictions accept a certificate or test report as credible evidence of cybersecurity compliance.

Medical devices increasingly depend on wireless networks, cloud platforms, remote monitoring, software updates, artificial intelligence, and electronic health records. A cybersecurity failure can therefore cause more than a data breach: it may interrupt treatment, alter diagnostic information, disable equipment, or endanger patients.

Examples include:

Insulin pumps vulnerable to unauthorised control.

Pacemakers and remote patient-monitoring systems exposed to malicious access.

MRI and CT scanners affected by ransomware.

AI diagnostic software vulnerable to data manipulation.

Hospital-connected infusion pumps exposed through insecure networks.

The central legal question is whether a recognised cybersecurity certificate provides evidence of compliance, creates a presumption of conformity, or is sufficient to satisfy a medical-device regulator. These are different legal consequences. A certificate may support regulatory approval without replacing the approval itself.

The IEEE Medical Device Cybersecurity Certification Program, for example, evaluates devices against the IEEE 2621 standards family and is intended to support regulatory submissions. The US Food and Drug Administration (FDA) also recognises specific consensus standards for medical-device cybersecurity.

IEEE Standards Association+1

2. Meaning and scope of recognition

Recognition refers to formal or practical acceptance of a certification scheme, its technical standards, its testing laboratories, or its certificates by a competent authority or procurement organisation.

There are five important forms of recognition.

1. Regulatory recognition

A regulator accepts a specified cybersecurity standard or certification as supporting evidence in a licensing or premarket assessment.

2. Mutual or cross-border recognition

One jurisdiction accepts certificates or conformity assessments issued under another jurisdiction's recognised framework, subject to the applicable agreement and scope.

3. Accreditation and laboratory recognition

A testing laboratory or certification body is authorised or accredited to conduct assessments within a defined technical scope.

4. Procurement recognition

A hospital or public purchasing authority accepts a certificate as a contractual qualification or evidence of security assurance.

5. Lifecycle recognition

The certification framework accounts for vulnerability disclosure, security updates, incident response, and continued security after a device enters the market.

These forms of recognition are not interchangeable. Accreditation of a laboratory does not automatically mean that every certificate it issues is accepted by every medical-device regulator.

3. Major international cybersecurity certification schemes

A. Singapore: Cybersecurity Labelling Scheme for Medical Devices (CLS(MD))

Dedicated medical-device scheme

Singapore launched CLS(MD) on 16 October 2024 as a voluntary scheme developed by the Cyber Security Agency (CSA), Ministry of Health, Health Sciences Authority (HSA), and Synapxe. It is specifically designed for connected medical devices and uses four progressively stronger cybersecurity levels.

Cyber Security Agency of Singapore+1

L1

Level 1 — Baseline

The device meets baseline cybersecurity requirements.

L2

Level 2 — Enhanced protection

The device meets additional cybersecurity requirements beyond the baseline.

L3

Level 3 — Independent security testing

Enhanced requirements plus independent third-party software-binary analysis and penetration testing.

L4

Level 4 — Advanced security evaluation

Enhanced requirements plus independent third-party software-binary analysis and security evaluation.

The scheme covers devices that handle personal or clinical data, or connect to other devices, systems, or services. Higher certification levels offer additional evidence of testing, but a higher label is not a guarantee that a device cannot be compromised.

Cyber Security Agency of Singapore+1

Legal significance: CLS(MD) illustrates how a government can create a device-specific recognition system without making every higher certification level a mandatory condition of market entry. Singapore's separate medical-device registration requirements continue to apply.

Official sources: CLS(MD) scheme overview and Scheme specifications and assessment documents.

B. United States: FDA recognition of consensus standards

The US system is based on statutory medical-device controls, FDA review, cybersecurity guidance, and recognition of technical standards. It is not a single universal cybersecurity certificate that automatically authorises a medical device for sale.

The principal legal instrument is section 524B of the Federal Food, Drug, and Cosmetic Act, added by the Consolidated Appropriations Act, 2023. For devices meeting the statutory definition of a cyber device, the sponsor must provide specified cybersecurity information in applicable premarket submissions. The requirements include:

A plan to monitor, identify, and address cybersecurity vulnerabilities and exploits.

Processes to provide reasonable assurance of cybersecurity throughout the device's lifecycle.

Procedures for making postmarket updates and patches available.

A software bill of materials (SBOM), including relevant commercial, open-source, and off-the-shelf components.

These statutory requirements apply to covered submissions made from 29 March 2023, subject to the law's scope and transition provisions.

FDA+1

The FDA issued updated final guidance in February 2026 on cybersecurity, quality-management-system considerations, and premarket submissions. Its guidance recommends how manufacturers should document and address cybersecurity risks; the binding legal obligations arise from applicable statutes and regulations, rather than from every recommendation in guidance.

FDA+1

One relevant standard is the IEEE 2621 series. The IEEE certification program provides a structured testing and reporting process, and IEEE states that FDA has designated IEEE 2621.2 as a recognised consensus standard. However, even recognised-standard conformity does not necessarily establish compliance with every applicable statutory requirement.

IEEE Standards Association+1

Official sources: FDA cybersecurity FAQs and FDA cybersecurity guidance, February 2026.

C. European Union: EU cybersecurity certification and medical-device conformity

The EU cybersecurity certification framework under Regulation (EU) 2019/881, known as the Cybersecurity Act, provides a mechanism for cybersecurity certification of ICT products, services, and processes. The EUCC scheme, based on Common Criteria, became applicable on 27 February 2025.

Shaping Europe’s digital future+1

For medical devices, however, the principal sector-specific legislation remains:

Regulation (EU) 2017/745 — Medical Devices Regulation (MDR).

Regulation (EU) 2017/746 — In Vitro Diagnostic Medical Devices Regulation (IVDR).

Their general safety and performance requirements address security risks associated with software and electronic systems. Manufacturers must consider cybersecurity as part of risk management, design, validation, and lifecycle controls.

The distinction is important: an EUCC certificate is not automatically a certificate of conformity with the MDR or IVDR. The certificate's scope, the device's intended purpose, the applicable medical-device requirements, and the relevant conformity-assessment route must all be considered. The EU's 2025 guidance on medical-device AI also discusses cybersecurity as part of the applicable risk-management and conformity-assessment framework.

Public Health+1

Official source: EU Cybersecurity Certification Framework.

D. India: CDSCO and the Medical Devices Rules, 2017

In India, medical devices are regulated under the Drugs and Cosmetics Act, 1940, and the Medical Devices Rules, 2017. The Central Drugs Standard Control Organisation (CDSCO) oversees the central regulatory functions, including imports and the manufacture of Class C and Class D devices; other licensing functions are allocated according to the applicable rules.

CDSCO+1

A cybersecurity certificate should therefore be assessed alongside the applicable Indian licensing, safety, quality-management, and documentation requirements. A foreign certificate or voluntary industry label does not, merely by existing, replace the required Indian regulatory licence.

A CDSCO circular dated 17 November 2025 further states that the applicable CDSCO or State/UT licensing authority approval must be a mandatory procurement requirement, with other certifications required by procurement agencies being additional to that approval.

CDSCO+1

For Indian manufacturers and importers, a defensible compliance strategy is to maintain:

The applicable medical-device licence or registration.

A cybersecurity risk assessment and documented security controls.

Evidence of software verification, vulnerability testing, and remediation.

A software component inventory and an update-support policy.

Any additional cybersecurity certificates required by the purchasing institution or applicable contract.

The exact legal requirements depend on device classification, intended use, connectivity, and the regulations applicable to the particular product.

Official sources: Medical Devices Rules, 2017 and CDSCO medical-device information.

4. Comparison of the principal approaches

The schemes differ in legal effect. Recognition should always be checked against the exact certificate, device category, issuing body, standard version, validity period, and intended regulatory use.

5. Important case laws and their legal principles

A key qualification is necessary: there is limited reported case law directly deciding whether a medical-device cybersecurity certification scheme must be recognised across jurisdictions. The following decisions are relevant because they establish principles concerning cybersecurity representations, medical-device regulation, product liability, and regulatory pre-emption. They should not be treated as judgments that specifically approved IEEE 2621 or Singapore CLS(MD).

Case 1: FTC v. Wyndham Worldwide Corp.

United States Court of Appeals for the Third Circuit, 2015

Citation: 799 F.3d 236 (3d Cir. 2015).

Facts: The US Federal Trade Commission challenged Wyndham over allegedly unreasonable cybersecurity practices associated with repeated data breaches affecting its hotel operations and customers.

Legal issue: Whether the FTC could challenge allegedly unfair cybersecurity practices under its statutory consumer-protection authority.

Decision: The Third Circuit upheld the FTC's authority to bring the enforcement action and rejected Wyndham's challenge at that stage of the litigation.

Relevance to medical-device certification:

A company cannot necessarily avoid legal scrutiny simply because it claims to follow industry practices.

Security representations made to customers and regulators may have legal consequences.

Certification may provide useful evidence of security controls, but it does not create blanket immunity from enforcement.

Principle: Cybersecurity compliance must be assessed against applicable legal duties and the actual security practices of the organisation, not merely the existence of a certificate.

This is an analogous cybersecurity decision, not a medical-device certification case.

Case 2: Riegel v. Medtronic, Inc.

Supreme Court of the United States, 2008

Citation: 552 U.S. 312 (2008).

Facts: The litigation concerned injuries allegedly caused by a Medtronic balloon catheter that had received premarket approval from the FDA.

Legal issue: Whether the Medical Device Amendments to the Federal Food, Drug, and Cosmetic Act pre-empted certain state-law product-liability claims concerning an FDA-approved medical device.

Decision: The Supreme Court held that the statutory pre-emption provision barred the state-law claims at issue because they imposed requirements different from or additional to the federal requirements applicable to the device.

Relevance to cybersecurity certification:

The judgment demonstrates the importance of identifying the precise legal effect of regulatory approval. A cybersecurity certificate is not equivalent to FDA premarket approval, and the pre-emption analysis applicable to an approved device cannot simply be transferred to a voluntary certification programme.

A cybersecurity defect may raise separate questions involving federal requirements, state law, contractual duties, and the particular circumstances of an injury.

Principle: The legal consequences of certification depend on the governing statute and the nature of the approval, rather than on the label attached to the product.

Case 3: Medtronic, Inc. v. Lohr

Supreme Court of the United States, 1996

Citation: 518 U.S. 470 (1996).

Facts: The case concerned state-law negligence and product-liability claims involving a Medtronic pacemaker lead cleared through the FDA's 510(k) process.

Legal issue: Whether the federal medical-device pre-emption provision barred the claims.

Decision: The Court concluded that the claims before it were not pre-empted on the basis asserted. Its reasoning distinguished the 510(k) clearance process from the more extensive premarket approval process at issue in Riegel.

Relevance to certification recognition:

The case illustrates that regulatory pathways are not interchangeable. A cybersecurity test report, a voluntary label, a 510(k) clearance, and a premarket approval have different legal meanings.

A manufacturer should not represent a cybersecurity certificate as equivalent to a regulator's substantive approval unless the relevant legal framework expressly supports that representation.

Principle: The legal effect of regulatory recognition depends on the specific procedure and statutory framework involved.

Case 4: Jacob Mathew v. State of Punjab

Supreme Court of India, 2005

Citation: (2005) 6 SCC 1.

Facts: The case concerned allegations of medical negligence following a patient's death and examined the standard required for criminal liability of medical professionals.

Legal issue: The circumstances in which a medical professional's conduct amounts to criminal negligence.

Decision: The Supreme Court explained the demanding standard applicable to criminal negligence in professional medical practice and distinguished civil negligence from criminal culpability.

Relevance to cybersecurity certification:

Although the case does not concern cybersecurity or manufacturers' certificates, it is relevant to the broader distinction between a poor outcome and legally culpable conduct.

If a cyberattack disables a medical device, a court would need to examine the applicable duty of care, the conduct of the parties, causation, and the relevant legal standard. Certification may be evidence of precautions taken, but it would not automatically determine whether negligence occurred.

Principle: Liability requires application of the relevant legal elements to the evidence; the existence or absence of a certification label does not by itself resolve liability.

Case 5: Spring Meadows Hospital v. Harjol Ahluwalia

Supreme Court of India, 1998

Citation: (1998) 4 SCC 39.

Facts: The case involved serious injury to a child following negligent medical treatment at a hospital.

Legal issue: Liability and compensation under consumer-protection law in the context of medical services.

Decision: The Supreme Court upheld the relevance of consumer-protection remedies and addressed the rights of the affected child and parents.

Relevance to connected medical devices:

A hospital's deployment of a connected medical device involves more than purchasing equipment. Appropriate configuration, maintenance, staff training, network security, and incident response may all be relevant to the applicable duty of care.

If an insecure device contributes to patient injury, responsibility may need to be examined across the manufacturer, hospital, service provider, and other relevant parties.

The case does not establish a cybersecurity-specific duty or a rule about certificate recognition; its relevance is by analogy to healthcare-service liability.

6. Legal principles emerging from the case law

The cases above support several useful distinctions.

7. Legal challenges in recognising cybersecurity certificates

A. Mutual recognition and jurisdictional differences

A certificate issued in one country may not satisfy another country's requirements. The second jurisdiction may require different tests, documentation, risk classifications, or post-market obligations.

A mutual-recognition arrangement can reduce duplicate testing, but its scope must be verified. Recognition of a testing laboratory does not necessarily mean recognition of every product certificate.

B. Changing cybersecurity threats

Certification represents an assessment against particular criteria at a particular time. New vulnerabilities may emerge after testing.

A legally robust scheme should therefore address:

Security-update availability and support periods.

Coordinated vulnerability disclosure.

Reassessment after significant software or hardware changes.

Revocation or suspension of labels when scheme conditions are no longer met.

Incident reporting and remediation.

C. Medical safety versus cybersecurity

A security control can itself create clinical risks. For example, a software update that fixes a vulnerability might interrupt a life-sustaining device if improperly validated.

Certification must therefore evaluate security in the context of the device's intended clinical function. Manufacturers should integrate cybersecurity into the quality-management and risk-management systems rather than treat it as a separate IT exercise.

D. False or misleading certification claims

A manufacturer that advertises a device as regulator-approved when it holds only a voluntary cybersecurity certificate may create consumer-protection, procurement, or contractual issues.

Likewise, an expired certificate or a certificate covering a different software version may not substantiate a claim about the device currently being sold.

E. Allocation of responsibility

A cybersecurity incident can involve multiple parties:

The manufacturer, responsible for design and applicable product-security obligations.

The software supplier, responsible for its contractual and legal obligations.

The hospital, responsible for applicable deployment and operational controls.

The certification body, responsible for the duties arising from its assessment and certification activities.

The regulator, responsible for exercising its statutory functions.

The allocation of liability depends on applicable law, contractual arrangements, the facts, and causation. Certification alone does not settle it.

8. Recommended legal and compliance framework

For a manufacturer seeking recognition in multiple markets, the following approach is practical.

Identify applicable regulatory pathways. Determine the device's classification, intended purpose, software status, and market-specific licensing requirements.

Select suitable technical standards. Assess relevant medical-device cybersecurity standards, including applicable IEC 81001-5-1, ISO 14971, and recognised standards appropriate to the device. Verify the current editions and regulatory status in each target market.

Use competent assessment bodies. Confirm that the laboratory or certification body is recognised for the relevant tests and scope.

Maintain technical evidence. Retain risk assessments, threat models, test reports, software inventories, vulnerability records, and remediation evidence.

Maintain security after launch. Establish a vulnerability-disclosure process, patch policy, support period, and incident-response plan.

Verify cross-border recognition. Check whether the receiving authority accepts the particular scheme, certificate, standard version, and conformity-assessment body.

Control certification claims. State precisely what was tested, which version was assessed, what the certificate covers, and when it expires.

9. Conclusion

Cybersecurity certification schemes for medical devices recognition form an important part of modern medical-device governance. They improve transparency, encourage independent testing, support procurement decisions, and may reduce duplicated conformity-assessment work.

The principal legal distinction is between recognition of a cybersecurity standard, acceptance of a certificate as evidence, and approval of a medical device for market entry. These are separate questions.

Singapore's CLS(MD) offers a dedicated voluntary labelling model; the US combines statutory cybersecurity obligations with FDA-recognised standards; the EU combines medical-device conformity rules with its broader cybersecurity certification framework; and India requires compliance with the applicable medical-device licensing regime, alongside any additional certification conditions.

The cited court decisions provide analogous principles concerning cybersecurity enforcement, regulatory approval, pre-emption, and medical negligence. They do not establish a universal judicial rule requiring cross-border recognition of medical-device cybersecurity certificates.

Scope note: This is a comparative legal overview, not a jurisdiction-specific legal opinion. For an actual certification or procurement decision, the current regulations, certificate scope, and applicable regulator's requirements should be verified.